APAC ePharmacy Market

APAC ePharmacy Market Size (2022 to 2027)

As per our research report, the Asia Pacific Online Pharmacy Market is expected to have robust growth from 2022 to 2027. The global market was led by the Asia Pacific due to the acceptance of the latest technological developments in the medical sector. India and China are significant contributors to have prominent shares of the market in this region. In addition, the rise in the government's stringent rules and regulations and the increasing demand for convenient and easy procedures through the internet is escalating the market's growth in this region.

The emergence of e-commerce in the medical sector is propelling the demand of the market to the extent. In addition, the rise in the prevalence of electronic devices instead of paperwork is also accelerating the market's growth.

Increasing revenue in most countries and the launch of various online stores merely spur growth opportunities for the market. Growing incidences of chronic diseases and other certain health disorders are bolstering the demand for this regional market.

However, an increasing number of fraudulent activities are impeding the demand for the APAC market. In addition, rapid changes in economic strategies are limiting the growth of the market.

This research report on the Asia-Pacific ePharmacy Market has been segmented and sub-segmented into the following categories:

By Product Type: 

• Skin Care
• Cold And Flu
• Vitamin
• Dental Care
• Weight Loss
• Others

By Drug Type: 

• Prescription Drugs
• Over The Counter (OTC)

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest Of APAC

Geographically, it is forecasted that the Indian ePharmacy market is estimated to be worth USD 3.1 billion by the end of 2025. There is excellent scope for the ePharmacy market as the online purchase of medicine is growing. The growing use of the internet and the 4G network availability even in the rural areas are propelling the market. In addition, the increasing rate of chronic diseases which require regular medicine is boosting the market growth. The government is also adopting online healthcare, which is helping in the growth of the ePharmacy market. 

The Chinese ePharmacy market will have a significant growth rate following India and will have steady growth in the coming years. Government initiatives in providing require sources to establish ePharmacy are fuelling the market demand in his country. 

Selling online prescription drugs is illegal in Japan, with some exceptions.

The ePharmacy market is growing significantly in Australia. The government is focusing on improving the e-pharmacy by creating awareness among people is solely to fuel the demand of the market. In addition, the government pharmaceutical benefits scheme (PBS) has limited the payment on most of the medication, allowing the retail pharmacist to give a discount of only 1$, which is to provide growth opportunities for the market.

KEY MARKET PLAYERS:

A few of the prominent players in the Asia Pacific ePharmacy Market profiled in the report are Giant Eagle, Inc., Express Scripts Holding Company., Rowlands Pharmacy, Optum Rx, Inc., Banner Health, PlanetRX.com, Lloyds Pharmacy Ltd, and Drugstore.com.